Page last updated: 2024-11-05

thalidomide and Hemangiosarcoma

thalidomide has been researched along with Hemangiosarcoma in 5 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Hemangiosarcoma: A rare malignant neoplasm characterized by rapidly proliferating, extensively infiltrating, anaplastic cells derived from blood vessels and lining irregular blood-filled or lumpy spaces. (Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"To investigate thalidomide as an adjuvant treatment for canine haemangiosarcoma."7.88Does thalidomide prolong survival in dogs with splenic haemangiosarcoma? ( Bray, JP; Cave, N; Munday, JS; Orbell, G, 2018)
"To investigate thalidomide as an adjuvant treatment for canine haemangiosarcoma."3.88Does thalidomide prolong survival in dogs with splenic haemangiosarcoma? ( Bray, JP; Cave, N; Munday, JS; Orbell, G, 2018)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bray, JP1
Orbell, G1
Cave, N1
Munday, JS1
Kayaci, S1
Yildiz, O1
Gucer, H1
Mandel, NM1
Fraiman, G1
Ganti, AK1
Potti, A1
Mehdi, S1
Raina, V1
Sengar, M1
Shukla, NK1
Deo, SS1
Mohanty, BK1
Sharma, D1
Ray, R1
Das, P1
Rath, GK1
Roe, FJ1
Walters, MA1

Other Studies

5 other studies available for thalidomide and Hemangiosarcoma

ArticleYear
Does thalidomide prolong survival in dogs with splenic haemangiosarcoma?
    The Journal of small animal practice, 2018, Volume: 59, Issue:2

    Topics: Angiogenesis Inhibitors; Animals; Chemotherapy, Adjuvant; Dog Diseases; Dogs; Female; Hemangiosarcom

2018
Angiosarcoma of the liver with metastasis to the cervical spine cured with the treatment of thalidomide and radiotherapy.
    Acta neurochirurgica, 2012, Volume: 154, Issue:2

    Topics: Angiogenesis Inhibitors; Biopsy; Cervical Vertebrae; Chemoradiotherapy; Hemangiosarcoma; Humans; Liv

2012
Angiosarcoma of the small intestine: a possible role for thalidomide?
    Medical oncology (Northwood, London, England), 2003, Volume: 20, Issue:4

    Topics: Aged; Aged, 80 and over; Anemia, Iron-Deficiency; Angiogenesis Inhibitors; Hemangiosarcoma; Humans;

2003
Complete response from thalidomide in angiosarcoma after treatment of breast cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Mar-01, Volume: 25, Issue:7

    Topics: Aged; Breast Neoplasms; Female; Hemangiosarcoma; Humans; Thalidomide

2007
Sensitivity of newborn mice to carcinogenic agents.
    Food and cosmetics toxicology, 1968, Volume: 6, Issue:5

    Topics: Adenocarcinoma; Adenoma; Animals; Animals, Newborn; Benz(a)Anthracenes; Carcinogens; Carcinoma, Hepa

1968